Abstract:Objectives: To study the incidence, spatial distribution, and signal characteristics of high frequency oscillations (HFOs) outside the epileptic network. Methods: We included patients who underwent invasive evaluations at Yale Comprehensive Epilepsy Center from 2012 to 2013, had all major lobes sampled, and had localizable seizure onsets. Segments of non-rapid eye movement (NREM) sleep prior to the first seizure were analyzed. We implemented a semiautomated process to analyze oscillations with peak frequencies >80 Hz (ripples 80-250 Hz; fast ripples 250-500 Hz). A contact location was considered epileptic if it exhibited epileptiform discharges during the intracranial evaluation or was involved ictally within 5 s of seizure onset; otherwise it was considered nonepileptic. Results: We analyzed recordings from 1,209 electrode contacts in seven patients. The nonepileptic contacts constituted 79.1% of the total number of contacts. Ripples constituted 99% of total detections. Eighty-two percent of all HFOs were seen in 45.2% of the nonepileptic contacts (82.1%, 47%, 34.6%, and 34% of the occipital, parietal, frontal, and temporal nonepileptic contacts, respectively). The following sublobes exhibited physiologic HFOs in all patients: Perirolandic, basal temporal, and occipital subregions. The ripples from nonepileptic sites had longer duration, higher amplitude, and lower peak frequency than ripples from epileptic sites. A high HFO rate (>1/min) was seen in 110 nonepileptic contacts, of which 68.2% were occipital. Fast ripples were less common, seen in nonepileptic parietooccipital regions only in two patients and in the epileptic mesial temporal structures. Conclusions: There is consistent occurrence of physiologic HFOs over vast areas of the neocortex outside the epileptic network. HFOs from nonepileptic regions were seen in the occipital lobes and in the perirolandic region in all patients. Although duration of ripples and peak frequency of HFOs are the most effective measures in distinguishing pathologic from physiologic events, there was significant overlap between the two groups.

Epileptogenic high-frequency oscillations present larger amplitude both in mesial temporal and neocortical regions

Pathological and Physiological High-frequency Oscillations on Electroencephalography in Patients with Epilepsy.

An Automatic HFO Detection Method Combining Visual Inspection Features with Multi-Domain Features

Expert Consensus on Clinical Applications of High-Frequency Oscillations in Epilepsy

Characterizing physiological high-frequency oscillations using deep learning

Spontaneous HFO Sequences Reveal Propagation Pathways for Precise Delineation of Epileptogenic Networks

Localizing epileptogenic regions using high-frequency oscillations and machine learning

Amplitude of high frequency oscillations as a biomarker of the seizure onset zone

HFO to Measure Seizure Propensity and Improve Prognostication in Patients With Epilepsy

Self-Supervised Data-Driven Approach Defines Pathological High-Frequency Oscillations in Human

Epileptic tissue localization using graph-based networks in the high frequency oscillation range of intracranial electroencephalography

Scalp HFO rates are higher for larger lesions

The spatial and signal characteristics of physiologic high frequency oscillations

Classifying High-Frequency Oscillations by Morphologic Contrast to Background, With Surgical Outcome Correlates

Prognostic value of high-frequency oscillations combined with multimodal imaging methods for epilepsy surgery

High-Frequency Oscillations in Epilepsy What Have We Learned and What Needs to be Addressed

Detection of anomalous high‐frequency events in human intracranial EEG

Optimizing detection and deep learning-based classification of pathological high-frequency oscillations in epilepsy

Detecting Continuous High-frequency Oscillations in Intracranial EEG from Patients with Epilepsy

Application of HFO and scaling analysis of neuronal oscillations in the presurgical evaluation of focal epilepsy

High frequency oscillations in intracranial EEGs mark epileptogenicity rather than lesion type